PARP1 and neoplasm: Recent data support the notion that the effectiveness of Wee1 inhibitors relies on an interplay between replication stress and cell cycle checkpoint failure, as evidenced through combined inhibition of PARP and Wee1, which appears to confer tumor-specific radiosensitization of HPV(+) HNSCC cells [174].